| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiac Catheterization | 79 | 2026 | 630 | 11.970 |
Why?
|
| Ductus Arteriosus, Patent | 27 | 2025 | 150 | 8.800 |
Why?
|
| Pulmonary Valve | 25 | 2026 | 83 | 6.020 |
Why?
|
| Septal Occluder Device | 13 | 2026 | 53 | 5.290 |
Why?
|
| Heart Septal Defects, Atrial | 16 | 2026 | 138 | 5.270 |
Why?
|
| Stents | 38 | 2025 | 799 | 4.370 |
Why?
|
| Heart Valve Prosthesis Implantation | 25 | 2026 | 425 | 4.270 |
Why?
|
| Ductus Arteriosus | 14 | 2025 | 59 | 4.220 |
Why?
|
| Pulmonary Artery | 29 | 2024 | 434 | 3.930 |
Why?
|
| Blalock-Taussig Procedure | 14 | 2023 | 46 | 3.870 |
Why?
|
| Heart Valve Prosthesis | 21 | 2026 | 303 | 3.800 |
Why?
|
| Tetralogy of Fallot | 17 | 2026 | 170 | 3.410 |
Why?
|
| Heart Defects, Congenital | 36 | 2024 | 1889 | 3.330 |
Why?
|
| Pulmonary Circulation | 17 | 2025 | 113 | 2.960 |
Why?
|
| Palliative Care | 18 | 2023 | 443 | 2.890 |
Why?
|
| Pulmonary Valve Insufficiency | 11 | 2026 | 35 | 2.710 |
Why?
|
| Treatment Outcome | 108 | 2026 | 12936 | 2.650 |
Why?
|
| Prosthesis Design | 28 | 2026 | 643 | 2.570 |
Why?
|
| Coronary Vessel Anomalies | 16 | 2023 | 279 | 2.370 |
Why?
|
| Coronary Angiography | 19 | 2024 | 450 | 2.330 |
Why?
|
| Heart-Assist Devices | 10 | 2022 | 1020 | 2.030 |
Why?
|
| Cardiac Surgical Procedures | 20 | 2025 | 1168 | 2.020 |
Why?
|
| Pulmonary Veins | 10 | 2024 | 167 | 2.000 |
Why?
|
| Ventricular Function, Right | 5 | 2025 | 126 | 1.820 |
Why?
|
| Vascular Fistula | 4 | 2021 | 25 | 1.810 |
Why?
|
| Infant, Newborn | 64 | 2026 | 8635 | 1.740 |
Why?
|
| Retrospective Studies | 98 | 2026 | 17753 | 1.720 |
Why?
|
| Coronary Vessels | 12 | 2023 | 521 | 1.720 |
Why?
|
| Prosthesis Implantation | 4 | 2020 | 152 | 1.650 |
Why?
|
| Ultrasonography, Interventional | 7 | 2019 | 205 | 1.650 |
Why?
|
| Heart Ventricles | 15 | 2024 | 749 | 1.590 |
Why?
|
| Fractional Flow Reserve, Myocardial | 6 | 2021 | 54 | 1.560 |
Why?
|
| Humans | 196 | 2026 | 131163 | 1.500 |
Why?
|
| Time Factors | 40 | 2026 | 6196 | 1.440 |
Why?
|
| Infant | 60 | 2026 | 13352 | 1.430 |
Why?
|
| Aorta, Thoracic | 8 | 2021 | 530 | 1.380 |
Why?
|
| Hemodynamics | 23 | 2026 | 810 | 1.370 |
Why?
|
| Pulmonary Atresia | 10 | 2024 | 48 | 1.300 |
Why?
|
| Heart Failure | 9 | 2022 | 2332 | 1.280 |
Why?
|
| Child | 84 | 2026 | 26341 | 1.260 |
Why?
|
| Hypertension, Pulmonary | 5 | 2025 | 457 | 1.220 |
Why?
|
| Bioprosthesis | 6 | 2024 | 110 | 1.210 |
Why?
|
| Child, Preschool | 54 | 2026 | 15110 | 1.200 |
Why?
|
| Embolization, Therapeutic | 3 | 2023 | 233 | 1.190 |
Why?
|
| Aorta | 11 | 2023 | 521 | 1.180 |
Why?
|
| Postoperative Complications | 15 | 2026 | 3147 | 1.170 |
Why?
|
| Adolescent | 67 | 2026 | 20987 | 1.170 |
Why?
|
| Catheterization, Peripheral | 6 | 2019 | 118 | 1.150 |
Why?
|
| Female | 109 | 2026 | 70963 | 1.140 |
Why?
|
| Body Weight | 4 | 2026 | 987 | 1.130 |
Why?
|
| Coronary Artery Disease | 6 | 2023 | 887 | 1.090 |
Why?
|
| Ventricular Dysfunction, Right | 2 | 2019 | 77 | 1.090 |
Why?
|
| Male | 106 | 2026 | 64957 | 1.080 |
Why?
|
| Aortic Coarctation | 3 | 2023 | 99 | 1.050 |
Why?
|
| Atrial Fibrillation | 5 | 2024 | 738 | 1.050 |
Why?
|
| Scimitar Syndrome | 4 | 2021 | 51 | 1.040 |
Why?
|
| Ventricular Function, Left | 4 | 2022 | 549 | 1.020 |
Why?
|
| Device Removal | 5 | 2024 | 225 | 1.020 |
Why?
|
| Hypoplastic Left Heart Syndrome | 6 | 2025 | 261 | 1.010 |
Why?
|
| Thrombosis | 5 | 2019 | 499 | 1.000 |
Why?
|
| Cyanosis | 4 | 2025 | 41 | 1.000 |
Why?
|
| Stenosis, Pulmonary Vein | 3 | 2024 | 23 | 0.970 |
Why?
|
| Heart Septal Defects, Ventricular | 4 | 2026 | 132 | 0.970 |
Why?
|
| Fetal Heart | 2 | 2025 | 132 | 0.960 |
Why?
|
| Foramen Ovale, Patent | 4 | 2021 | 13 | 0.940 |
Why?
|
| Catheterization, Central Venous | 3 | 2014 | 143 | 0.930 |
Why?
|
| Angioplasty, Balloon | 7 | 2024 | 122 | 0.890 |
Why?
|
| Drug-Eluting Stents | 3 | 2021 | 67 | 0.870 |
Why?
|
| Young Adult | 36 | 2026 | 10103 | 0.860 |
Why?
|
| Reoperation | 11 | 2022 | 818 | 0.850 |
Why?
|
| Echocardiography | 15 | 2024 | 1125 | 0.850 |
Why?
|
| Prosthesis Failure | 6 | 2024 | 159 | 0.830 |
Why?
|
| Aneurysm, False | 2 | 2023 | 84 | 0.800 |
Why?
|
| Diverticulum | 1 | 2023 | 22 | 0.780 |
Why?
|
| Heart Aneurysm | 1 | 2023 | 27 | 0.780 |
Why?
|
| Computed Tomography Angiography | 7 | 2024 | 216 | 0.770 |
Why?
|
| Atrial Appendage | 1 | 2024 | 77 | 0.770 |
Why?
|
| Registries | 11 | 2026 | 1634 | 0.750 |
Why?
|
| Dyspnea | 4 | 2019 | 159 | 0.750 |
Why?
|
| Constriction, Pathologic | 4 | 2022 | 221 | 0.750 |
Why?
|
| Arterial Occlusive Diseases | 4 | 2019 | 99 | 0.740 |
Why?
|
| Catheter Ablation | 4 | 2017 | 324 | 0.730 |
Why?
|
| Recovery of Function | 12 | 2026 | 449 | 0.720 |
Why?
|
| Myocardial Bridging | 2 | 2024 | 14 | 0.710 |
Why?
|
| Risk Factors | 30 | 2026 | 11074 | 0.680 |
Why?
|
| United States | 27 | 2026 | 12072 | 0.670 |
Why?
|
| Heart Atria | 5 | 2020 | 343 | 0.670 |
Why?
|
| Patient Selection | 4 | 2024 | 729 | 0.660 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2021 | 83 | 0.640 |
Why?
|
| Pulmonary Valve Stenosis | 2 | 2018 | 36 | 0.630 |
Why?
|
| Coronary Stenosis | 2 | 2021 | 78 | 0.630 |
Why?
|
| Adult | 48 | 2026 | 31282 | 0.630 |
Why?
|
| Vascular Access Devices | 2 | 2017 | 31 | 0.630 |
Why?
|
| Clinical Decision-Making | 4 | 2024 | 314 | 0.610 |
Why?
|
| Balloon Valvuloplasty | 3 | 2020 | 27 | 0.610 |
Why?
|
| Blood Flow Velocity | 3 | 2019 | 417 | 0.610 |
Why?
|
| Predictive Value of Tests | 11 | 2024 | 2304 | 0.610 |
Why?
|
| Pulsatile Flow | 1 | 2019 | 110 | 0.600 |
Why?
|
| Body Height | 2 | 2019 | 192 | 0.590 |
Why?
|
| Catheterization | 3 | 2022 | 226 | 0.590 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2020 | 161 | 0.580 |
Why?
|
| Everolimus | 1 | 2019 | 50 | 0.580 |
Why?
|
| Thulium | 1 | 2019 | 12 | 0.580 |
Why?
|
| Hospitals, Pediatric | 3 | 2018 | 808 | 0.580 |
Why?
|
| Pericardial Effusion | 2 | 2025 | 78 | 0.580 |
Why?
|
| Thrombectomy | 2 | 2019 | 117 | 0.570 |
Why?
|
| Neonatologists | 1 | 2019 | 22 | 0.570 |
Why?
|
| Cardiologists | 1 | 2019 | 26 | 0.570 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2019 | 41 | 0.560 |
Why?
|
| Cardiotonic Agents | 1 | 2019 | 138 | 0.560 |
Why?
|
| Vasodilator Agents | 1 | 2019 | 197 | 0.550 |
Why?
|
| Hypertrophy, Right Ventricular | 1 | 2018 | 10 | 0.550 |
Why?
|
| Feasibility Studies | 11 | 2025 | 824 | 0.540 |
Why?
|
| Disease Management | 2 | 2019 | 558 | 0.530 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2018 | 104 | 0.530 |
Why?
|
| Kartagener Syndrome | 1 | 2017 | 12 | 0.530 |
Why?
|
| Venous Thrombosis | 2 | 2017 | 164 | 0.530 |
Why?
|
| Ventricular Outflow Obstruction | 5 | 2024 | 72 | 0.520 |
Why?
|
| Follow-Up Studies | 18 | 2022 | 5196 | 0.520 |
Why?
|
| Norwood Procedures | 4 | 2022 | 96 | 0.520 |
Why?
|
| Shock, Cardiogenic | 2 | 2022 | 176 | 0.510 |
Why?
|
| Ventricular Remodeling | 1 | 2018 | 155 | 0.510 |
Why?
|
| Thrombolytic Therapy | 1 | 2018 | 191 | 0.510 |
Why?
|
| Foreign-Body Migration | 1 | 2017 | 65 | 0.490 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2017 | 75 | 0.490 |
Why?
|
| Forecasting | 2 | 2018 | 351 | 0.490 |
Why?
|
| Myocardial Ischemia | 4 | 2023 | 307 | 0.490 |
Why?
|
| Fontan Procedure | 5 | 2023 | 180 | 0.480 |
Why?
|
| Endovascular Procedures | 7 | 2024 | 802 | 0.480 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2017 | 78 | 0.480 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 91 | 0.470 |
Why?
|
| Angiography | 7 | 2024 | 179 | 0.460 |
Why?
|
| Infant, Extremely Premature | 1 | 2016 | 113 | 0.460 |
Why?
|
| Risk Assessment | 12 | 2026 | 3711 | 0.450 |
Why?
|
| Texas | 12 | 2025 | 3686 | 0.450 |
Why?
|
| Age Factors | 11 | 2022 | 2825 | 0.420 |
Why?
|
| Catheters, Indwelling | 2 | 2013 | 140 | 0.420 |
Why?
|
| Vascular Surgical Procedures | 7 | 2022 | 534 | 0.410 |
Why?
|
| Death, Sudden, Cardiac | 4 | 2024 | 268 | 0.400 |
Why?
|
| Equipment Design | 5 | 2019 | 512 | 0.390 |
Why?
|
| Superior Vena Cava Syndrome | 1 | 2013 | 14 | 0.380 |
Why?
|
| Surveys and Questionnaires | 4 | 2021 | 4066 | 0.380 |
Why?
|
| Chylothorax | 1 | 2013 | 27 | 0.380 |
Why?
|
| Brachiocephalic Veins | 1 | 2012 | 12 | 0.380 |
Why?
|
| Venae Cavae | 1 | 2012 | 10 | 0.380 |
Why?
|
| Coronary Circulation | 6 | 2022 | 187 | 0.370 |
Why?
|
| Central Venous Catheters | 1 | 2013 | 50 | 0.370 |
Why?
|
| Tricuspid Valve | 2 | 2024 | 58 | 0.360 |
Why?
|
| Prospective Studies | 13 | 2025 | 6459 | 0.360 |
Why?
|
| Europe | 3 | 2024 | 365 | 0.360 |
Why?
|
| Atrial Septum | 2 | 2025 | 21 | 0.350 |
Why?
|
| Primary Health Care | 1 | 2017 | 775 | 0.340 |
Why?
|
| Diagnosis, Differential | 4 | 2023 | 1882 | 0.320 |
Why?
|
| Myocardial Perfusion Imaging | 5 | 2024 | 60 | 0.320 |
Why?
|
| Ventricular Septum | 2 | 2022 | 16 | 0.310 |
Why?
|
| Carotid Artery, Common | 2 | 2021 | 59 | 0.310 |
Why?
|
| Lung | 3 | 2021 | 1535 | 0.310 |
Why?
|
| Carotid Arteries | 2 | 2021 | 124 | 0.310 |
Why?
|
| Middle Aged | 26 | 2025 | 28601 | 0.300 |
Why?
|
| Stenosis, Pulmonary Artery | 2 | 2020 | 3 | 0.300 |
Why?
|
| Extracorporeal Membrane Oxygenation | 5 | 2020 | 682 | 0.300 |
Why?
|
| Abnormalities, Multiple | 5 | 2024 | 963 | 0.300 |
Why?
|
| Survival Rate | 8 | 2026 | 2114 | 0.300 |
Why?
|
| Pulmonary Embolism | 2 | 2024 | 182 | 0.300 |
Why?
|
| Axillary Artery | 2 | 2019 | 31 | 0.300 |
Why?
|
| Tachycardia, Ventricular | 2 | 2026 | 257 | 0.290 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 2 | 2013 | 25 | 0.290 |
Why?
|
| Asthma | 1 | 2017 | 922 | 0.290 |
Why?
|
| Vascular Patency | 6 | 2020 | 185 | 0.280 |
Why?
|
| Tricuspid Valve Insufficiency | 2 | 2020 | 61 | 0.280 |
Why?
|
| Mitral Valve Insufficiency | 2 | 2009 | 178 | 0.270 |
Why?
|
| Echocardiography, Doppler, Color | 5 | 2017 | 113 | 0.270 |
Why?
|
| Echocardiography, Transesophageal | 5 | 2023 | 246 | 0.270 |
Why?
|
| Angioplasty | 2 | 2020 | 63 | 0.270 |
Why?
|
| Pregnancy | 8 | 2026 | 7512 | 0.270 |
Why?
|
| Mitral Valve | 1 | 2009 | 247 | 0.260 |
Why?
|
| Ultrasonography, Prenatal | 3 | 2024 | 986 | 0.260 |
Why?
|
| Heart Transplantation | 3 | 2022 | 800 | 0.260 |
Why?
|
| Incidence | 6 | 2025 | 3360 | 0.260 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2024 | 2065 | 0.250 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 1826 | 0.250 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2026 | 27 | 0.240 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2023 | 3763 | 0.240 |
Why?
|
| Transcatheter Aortic Valve Replacement | 2 | 2019 | 228 | 0.240 |
Why?
|
| Transposition of Great Vessels | 3 | 2020 | 118 | 0.240 |
Why?
|
| Aortic Valve Insufficiency | 3 | 2019 | 149 | 0.230 |
Why?
|
| Models, Cardiovascular | 2 | 2024 | 165 | 0.230 |
Why?
|
| Ultrasonography, Doppler | 2 | 2019 | 187 | 0.220 |
Why?
|
| Arrhythmias, Cardiac | 3 | 2024 | 482 | 0.220 |
Why?
|
| Skin Pigmentation | 1 | 2025 | 29 | 0.220 |
Why?
|
| Canada | 1 | 2026 | 327 | 0.220 |
Why?
|
| Cohort Studies | 6 | 2024 | 5063 | 0.220 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2025 | 1280 | 0.220 |
Why?
|
| Fetal Therapies | 1 | 2026 | 94 | 0.220 |
Why?
|
| Quality of Life | 3 | 2025 | 2082 | 0.220 |
Why?
|
| Hospital Mortality | 3 | 2020 | 1064 | 0.210 |
Why?
|
| Vascular Closure Devices | 1 | 2024 | 9 | 0.210 |
Why?
|
| Splenic Vein | 1 | 2024 | 10 | 0.210 |
Why?
|
| Endocarditis | 3 | 2022 | 102 | 0.210 |
Why?
|
| Hepatic Veins | 1 | 2024 | 20 | 0.210 |
Why?
|
| Patient-Specific Modeling | 1 | 2024 | 12 | 0.210 |
Why?
|
| Exercise | 2 | 2021 | 892 | 0.210 |
Why?
|
| Decompression, Surgical | 3 | 2019 | 83 | 0.200 |
Why?
|
| Finite Element Analysis | 1 | 2024 | 39 | 0.200 |
Why?
|
| Oximetry | 1 | 2025 | 176 | 0.200 |
Why?
|
| Data Accuracy | 2 | 2021 | 29 | 0.200 |
Why?
|
| Aortic Valve | 3 | 2020 | 455 | 0.200 |
Why?
|
| Resuscitation | 1 | 2026 | 258 | 0.200 |
Why?
|
| Health Information Systems | 1 | 2023 | 34 | 0.190 |
Why?
|
| Retreatment | 4 | 2017 | 85 | 0.190 |
Why?
|
| Triiodobenzoic Acids | 2 | 2020 | 29 | 0.190 |
Why?
|
| Critical Illness | 1 | 2007 | 630 | 0.180 |
Why?
|
| Severity of Illness Index | 6 | 2025 | 3061 | 0.180 |
Why?
|
| Spinal Dysraphism | 1 | 2026 | 261 | 0.180 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2021 | 216 | 0.180 |
Why?
|
| DiGeorge Syndrome | 1 | 2023 | 83 | 0.180 |
Why?
|
| Blood Vessel Prosthesis Implantation | 3 | 2020 | 767 | 0.180 |
Why?
|
| Recurrent Laryngeal Nerve Injuries | 1 | 2022 | 14 | 0.180 |
Why?
|
| Recurrence | 5 | 2019 | 1489 | 0.180 |
Why?
|
| Electrocoagulation | 2 | 2023 | 30 | 0.180 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2022 | 60 | 0.180 |
Why?
|
| Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2022 | 15 | 0.180 |
Why?
|
| Placenta Diseases | 1 | 2022 | 55 | 0.180 |
Why?
|
| Patient Care Team | 2 | 2024 | 562 | 0.180 |
Why?
|
| Magnetic Resonance Imaging, Cine | 5 | 2023 | 176 | 0.180 |
Why?
|
| Fetoscopy | 1 | 2026 | 460 | 0.170 |
Why?
|
| Hemangioma | 1 | 2022 | 86 | 0.170 |
Why?
|
| Child Development | 2 | 2024 | 266 | 0.170 |
Why?
|
| Postoperative Period | 2 | 2020 | 331 | 0.170 |
Why?
|
| Esophageal and Gastric Varices | 1 | 2022 | 72 | 0.170 |
Why?
|
| Hypertension, Portal | 1 | 2022 | 78 | 0.170 |
Why?
|
| Vocal Cord Paralysis | 1 | 2022 | 68 | 0.160 |
Why?
|
| Coronary Sinus | 1 | 2021 | 12 | 0.160 |
Why?
|
| Comparative Effectiveness Research | 1 | 2021 | 73 | 0.160 |
Why?
|
| Coronary Thrombosis | 1 | 2021 | 33 | 0.160 |
Why?
|
| Risk Adjustment | 1 | 2021 | 55 | 0.160 |
Why?
|
| Patient Care Management | 1 | 2021 | 61 | 0.160 |
Why?
|
| Aortic Valve Stenosis | 2 | 2019 | 350 | 0.160 |
Why?
|
| Fistula | 1 | 2021 | 50 | 0.160 |
Why?
|
| Hemoptysis | 1 | 2020 | 22 | 0.160 |
Why?
|
| Exercise Test | 4 | 2024 | 239 | 0.160 |
Why?
|
| Heart Injuries | 1 | 2020 | 48 | 0.160 |
Why?
|
| Infant, Low Birth Weight | 1 | 2021 | 172 | 0.160 |
Why?
|
| Fetal Diseases | 1 | 2024 | 440 | 0.160 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2020 | 19 | 0.150 |
Why?
|
| Heart Septal Defects | 1 | 2020 | 42 | 0.150 |
Why?
|
| Health Care Rationing | 1 | 2020 | 58 | 0.150 |
Why?
|
| Feeding Methods | 1 | 2019 | 35 | 0.150 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2020 | 53 | 0.150 |
Why?
|
| Conservative Treatment | 1 | 2020 | 46 | 0.150 |
Why?
|
| Body Surface Area | 1 | 2019 | 36 | 0.150 |
Why?
|
| Iatrogenic Disease | 1 | 2020 | 121 | 0.150 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2019 | 29 | 0.150 |
Why?
|
| Contrast Media | 2 | 2020 | 474 | 0.150 |
Why?
|
| Patients | 1 | 2020 | 122 | 0.150 |
Why?
|
| Coronary Occlusion | 1 | 2019 | 34 | 0.150 |
Why?
|
| Patient Positioning | 1 | 2019 | 48 | 0.150 |
Why?
|
| Femoral Artery | 1 | 2019 | 134 | 0.140 |
Why?
|
| Punctures | 4 | 2019 | 52 | 0.140 |
Why?
|
| Phlebography | 2 | 2016 | 41 | 0.140 |
Why?
|
| Heart Septum | 1 | 2018 | 41 | 0.140 |
Why?
|
| Upper Extremity | 1 | 2019 | 53 | 0.140 |
Why?
|
| Metals | 1 | 2019 | 70 | 0.140 |
Why?
|
| Liver Transplantation | 2 | 2019 | 1147 | 0.140 |
Why?
|
| Aortography | 2 | 2016 | 155 | 0.140 |
Why?
|
| Hypertension, Renovascular | 1 | 2018 | 28 | 0.140 |
Why?
|
| Sinus of Valsalva | 1 | 2018 | 33 | 0.140 |
Why?
|
| Exercise Tolerance | 1 | 2019 | 91 | 0.140 |
Why?
|
| Hemodynamic Monitoring | 1 | 2018 | 17 | 0.140 |
Why?
|
| Drug Administration Schedule | 1 | 2019 | 732 | 0.140 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2019 | 119 | 0.140 |
Why?
|
| Heart | 2 | 2023 | 650 | 0.140 |
Why?
|
| Ventricular Function | 1 | 2018 | 81 | 0.130 |
Why?
|
| Prognosis | 4 | 2020 | 4886 | 0.130 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2019 | 135 | 0.130 |
Why?
|
| Gestational Age | 2 | 2025 | 1224 | 0.130 |
Why?
|
| Renal Artery Obstruction | 1 | 2018 | 40 | 0.130 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2018 | 80 | 0.130 |
Why?
|
| Physical Exertion | 1 | 2017 | 63 | 0.130 |
Why?
|
| Hospital Costs | 1 | 2019 | 188 | 0.130 |
Why?
|
| Peritoneal Dialysis, Continuous Ambulatory | 1 | 2017 | 22 | 0.130 |
Why?
|
| Radiography, Interventional | 3 | 2017 | 79 | 0.130 |
Why?
|
| Hemodiafiltration | 1 | 2017 | 17 | 0.130 |
Why?
|
| Jugular Veins | 1 | 2017 | 71 | 0.130 |
Why?
|
| Fibrinolytic Agents | 1 | 2018 | 182 | 0.130 |
Why?
|
| Equipment Failure | 1 | 2017 | 122 | 0.120 |
Why?
|
| Parents | 1 | 2024 | 1128 | 0.120 |
Why?
|
| Computer Simulation | 1 | 2020 | 674 | 0.120 |
Why?
|
| Tennessee | 1 | 2016 | 51 | 0.120 |
Why?
|
| Chest Pain | 1 | 2017 | 133 | 0.120 |
Why?
|
| Blood Vessel Prosthesis | 2 | 2018 | 492 | 0.120 |
Why?
|
| Myocardial Infarction | 2 | 2021 | 999 | 0.120 |
Why?
|
| Comorbidity | 2 | 2019 | 1595 | 0.120 |
Why?
|
| Infant Mortality | 1 | 2017 | 183 | 0.120 |
Why?
|
| Radiation Dosage | 2 | 2019 | 132 | 0.120 |
Why?
|
| Vascular Diseases | 1 | 2018 | 146 | 0.120 |
Why?
|
| Percutaneous Coronary Intervention | 2 | 2017 | 299 | 0.120 |
Why?
|
| Osteosarcoma | 1 | 2019 | 276 | 0.120 |
Why?
|
| Steroid Metabolism, Inborn Errors | 1 | 2015 | 3 | 0.120 |
Why?
|
| Cholic Acids | 1 | 2015 | 18 | 0.120 |
Why?
|
| Communication | 1 | 2020 | 543 | 0.110 |
Why?
|
| Tomography, Optical Coherence | 2 | 2017 | 441 | 0.110 |
Why?
|
| Morbidity | 3 | 2026 | 256 | 0.110 |
Why?
|
| Developmental Disabilities | 2 | 2024 | 781 | 0.110 |
Why?
|
| Acute Disease | 1 | 2018 | 1153 | 0.110 |
Why?
|
| Evidence-Based Medicine | 1 | 2019 | 645 | 0.110 |
Why?
|
| Transition to Adult Care | 1 | 2017 | 131 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2015 | 77 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 339 | 0.110 |
Why?
|
| Perioperative Care | 1 | 2017 | 217 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 351 | 0.110 |
Why?
|
| Immunosuppressive Agents | 1 | 2019 | 663 | 0.110 |
Why?
|
| Birth Weight | 1 | 2016 | 347 | 0.110 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2016 | 227 | 0.110 |
Why?
|
| Research Design | 1 | 2019 | 716 | 0.110 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2016 | 150 | 0.110 |
Why?
|
| Balloon Occlusion | 1 | 2015 | 48 | 0.110 |
Why?
|
| Renal Insufficiency | 1 | 2017 | 259 | 0.110 |
Why?
|
| Bone Neoplasms | 1 | 2019 | 475 | 0.100 |
Why?
|
| Cardiology | 1 | 2019 | 514 | 0.100 |
Why?
|
| Aged | 11 | 2019 | 21025 | 0.100 |
Why?
|
| Gene Duplication | 1 | 2015 | 358 | 0.100 |
Why?
|
| Length of Stay | 4 | 2023 | 1421 | 0.100 |
Why?
|
| Multicenter Studies as Topic | 2 | 2025 | 294 | 0.100 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 1490 | 0.090 |
Why?
|
| Li-Fraumeni Syndrome | 1 | 2013 | 49 | 0.090 |
Why?
|
| Patient Safety | 1 | 2017 | 443 | 0.090 |
Why?
|
| Stroke Volume | 1 | 2014 | 541 | 0.090 |
Why?
|
| Hirudins | 1 | 2011 | 39 | 0.080 |
Why?
|
| Anticoagulants | 3 | 2011 | 605 | 0.080 |
Why?
|
| Anesthesia, General | 1 | 2011 | 140 | 0.080 |
Why?
|
| Sarcoma | 1 | 2012 | 219 | 0.080 |
Why?
|
| Databases, Factual | 3 | 2020 | 1240 | 0.080 |
Why?
|
| Aortic Diseases | 1 | 2011 | 190 | 0.070 |
Why?
|
| Kidney Failure, Chronic | 1 | 2017 | 934 | 0.070 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2012 | 371 | 0.070 |
Why?
|
| Intracranial Embolism | 1 | 2008 | 26 | 0.070 |
Why?
|
| Preliminary Data | 2 | 2018 | 8 | 0.070 |
Why?
|
| Proportional Hazards Models | 2 | 2026 | 1410 | 0.070 |
Why?
|
| Receptors, LDL | 2 | 2019 | 106 | 0.060 |
Why?
|
| Stroke | 3 | 2012 | 1061 | 0.060 |
Why?
|
| Peptide Fragments | 1 | 2011 | 687 | 0.060 |
Why?
|
| Decision Support Techniques | 2 | 2020 | 293 | 0.060 |
Why?
|
| Electrocardiography | 3 | 2021 | 970 | 0.060 |
Why?
|
| Pragmatic Clinical Trials as Topic | 1 | 2025 | 35 | 0.060 |
Why?
|
| Sex Chromosome Disorders | 1 | 2004 | 9 | 0.050 |
Why?
|
| Monosomy | 1 | 2004 | 24 | 0.050 |
Why?
|
| Observational Studies as Topic | 1 | 2025 | 106 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2018 | 1071 | 0.050 |
Why?
|
| Executive Function | 1 | 2024 | 122 | 0.050 |
Why?
|
| Tomography, Spiral Computed | 1 | 2003 | 15 | 0.050 |
Why?
|
| Pandemics | 2 | 2021 | 1118 | 0.050 |
Why?
|
| Cause of Death | 1 | 2025 | 506 | 0.050 |
Why?
|
| Algorithms | 2 | 2020 | 1680 | 0.050 |
Why?
|
| Meningomyelocele | 1 | 2026 | 260 | 0.050 |
Why?
|
| Mosaicism | 1 | 2004 | 248 | 0.050 |
Why?
|
| Catheters | 1 | 2022 | 78 | 0.050 |
Why?
|
| Cardiopulmonary Bypass | 3 | 2012 | 361 | 0.050 |
Why?
|
| Hydrops Fetalis | 1 | 2022 | 82 | 0.040 |
Why?
|
| Viridans Streptococci | 1 | 2021 | 7 | 0.040 |
Why?
|
| Respiration, Artificial | 2 | 2021 | 501 | 0.040 |
Why?
|
| Portal Vein | 1 | 2022 | 84 | 0.040 |
Why?
|
| Ascites | 1 | 2022 | 99 | 0.040 |
Why?
|
| Acetaminophen | 1 | 2022 | 100 | 0.040 |
Why?
|
| International Cooperation | 1 | 2021 | 165 | 0.040 |
Why?
|
| Preoperative Care | 1 | 2023 | 358 | 0.040 |
Why?
|
| Ischemic Attack, Transient | 2 | 2012 | 58 | 0.040 |
Why?
|
| Arteries | 1 | 2021 | 208 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2025 | 798 | 0.040 |
Why?
|
| Collateral Circulation | 2 | 2012 | 42 | 0.040 |
Why?
|
| Personal Protective Equipment | 1 | 2020 | 36 | 0.040 |
Why?
|
| Resource Allocation | 1 | 2020 | 53 | 0.040 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2022 | 239 | 0.040 |
Why?
|
| Perfusion | 1 | 2021 | 209 | 0.040 |
Why?
|
| Ohio | 1 | 2019 | 85 | 0.040 |
Why?
|
| Ireland | 1 | 2019 | 33 | 0.040 |
Why?
|
| Pacemaker, Artificial | 1 | 2022 | 193 | 0.040 |
Why?
|
| Defibrillators, Implantable | 1 | 2022 | 215 | 0.040 |
Why?
|
| Pulmonary Ventilation | 1 | 2019 | 28 | 0.040 |
Why?
|
| Models, Economic | 1 | 2019 | 59 | 0.040 |
Why?
|
| Extracellular Space | 1 | 1999 | 79 | 0.040 |
Why?
|
| Cost Savings | 1 | 2019 | 79 | 0.040 |
Why?
|
| Hospitals | 1 | 2021 | 435 | 0.040 |
Why?
|
| Fluoroscopy | 1 | 2019 | 108 | 0.040 |
Why?
|
| Disease Progression | 1 | 2025 | 2200 | 0.030 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2018 | 56 | 0.030 |
Why?
|
| Age Distribution | 1 | 2019 | 422 | 0.030 |
Why?
|
| Mitral Valve Stenosis | 1 | 2018 | 32 | 0.030 |
Why?
|
| Program Development | 1 | 2019 | 179 | 0.030 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2024 | 629 | 0.030 |
Why?
|
| Placenta | 1 | 2022 | 504 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2019 | 294 | 0.030 |
Why?
|
| Heart Neoplasms | 1 | 2019 | 106 | 0.030 |
Why?
|
| Cerebrovascular Circulation | 1 | 2021 | 487 | 0.030 |
Why?
|
| Operative Time | 1 | 2019 | 201 | 0.030 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2021 | 361 | 0.030 |
Why?
|
| Hyperlipidemias | 1 | 2019 | 185 | 0.030 |
Why?
|
| Cooperative Behavior | 1 | 2019 | 224 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2021 | 483 | 0.030 |
Why?
|
| Michigan | 1 | 2017 | 47 | 0.030 |
Why?
|
| Iohexol | 1 | 2017 | 19 | 0.030 |
Why?
|
| Needles | 1 | 2017 | 48 | 0.030 |
Why?
|
| Replantation | 1 | 2017 | 51 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2019 | 447 | 0.030 |
Why?
|
| Weight Gain | 1 | 2019 | 393 | 0.030 |
Why?
|
| Betacoronavirus | 1 | 2020 | 275 | 0.030 |
Why?
|
| Drainage | 1 | 2018 | 250 | 0.030 |
Why?
|
| Telemetry | 1 | 2016 | 23 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 1999 | 420 | 0.030 |
Why?
|
| Heterografts | 1 | 2017 | 191 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2019 | 713 | 0.030 |
Why?
|
| Hypertension | 2 | 2019 | 1356 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2019 | 555 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2017 | 263 | 0.030 |
Why?
|
| Cattle | 1 | 2017 | 501 | 0.030 |
Why?
|
| Coronary Artery Bypass | 1 | 2020 | 515 | 0.030 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2020 | 500 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2017 | 563 | 0.030 |
Why?
|
| Pedigree | 1 | 2019 | 1677 | 0.030 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2016 | 159 | 0.030 |
Why?
|
| Gastric Mucosa | 1 | 1999 | 494 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 3829 | 0.030 |
Why?
|
| GATA4 Transcription Factor | 1 | 2015 | 35 | 0.030 |
Why?
|
| Pregnancy Outcome | 1 | 2018 | 623 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 905 | 0.030 |
Why?
|
| Liver Cirrhosis | 1 | 2022 | 903 | 0.030 |
Why?
|
| Decision Making | 1 | 2020 | 726 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 1211 | 0.030 |
Why?
|
| Calcium | 1 | 1999 | 1010 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 1378 | 0.030 |
Why?
|
| Logistic Models | 1 | 2018 | 1797 | 0.020 |
Why?
|
| Hematologic Agents | 1 | 2012 | 8 | 0.020 |
Why?
|
| Off-Label Use | 1 | 2012 | 29 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 2085 | 0.020 |
Why?
|
| Syndrome | 1 | 2015 | 1155 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 6797 | 0.020 |
Why?
|
| Sternotomy | 1 | 2012 | 41 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 2015 | 653 | 0.020 |
Why?
|
| Radiation Protection | 1 | 2012 | 51 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2019 | 889 | 0.020 |
Why?
|
| Herniorrhaphy | 1 | 2011 | 71 | 0.020 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2012 | 194 | 0.020 |
Why?
|
| DNA | 1 | 2015 | 1399 | 0.020 |
Why?
|
| Intraoperative Period | 1 | 2009 | 63 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2009 | 115 | 0.020 |
Why?
|
| Incidental Findings | 1 | 2009 | 122 | 0.020 |
Why?
|
| Echocardiography, Doppler | 1 | 2009 | 158 | 0.020 |
Why?
|
| Sex Factors | 1 | 2012 | 1356 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 2008 | 176 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2012 | 1267 | 0.020 |
Why?
|
| Risk | 1 | 2009 | 726 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2011 | 1319 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2011 | 487 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2009 | 1483 | 0.010 |
Why?
|
| Chromosomes, Human, Y | 1 | 2004 | 52 | 0.010 |
Why?
|
| Double Outlet Right Ventricle | 1 | 2004 | 19 | 0.010 |
Why?
|
| Chromosomes, Human, X | 1 | 2004 | 155 | 0.010 |
Why?
|
| Smoking | 1 | 2008 | 932 | 0.010 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2003 | 42 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 2003 | 227 | 0.010 |
Why?
|
| Mutation | 1 | 2015 | 6099 | 0.010 |
Why?
|
| Prevalence | 1 | 2008 | 2701 | 0.010 |
Why?
|
| Animals | 2 | 2017 | 33912 | 0.010 |
Why?
|
| Pregnancy Complications | 1 | 2004 | 567 | 0.010 |
Why?
|
| Receptors, Calcium-Sensing | 1 | 1999 | 11 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1999 | 234 | 0.010 |
Why?
|
| Parietal Cells, Gastric | 1 | 1999 | 38 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 1999 | 116 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1999 | 422 | 0.010 |
Why?
|
| Stomach | 1 | 1999 | 274 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 1205 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1999 | 1105 | 0.010 |
Why?
|
| RNA | 1 | 1999 | 517 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 1999 | 1591 | 0.010 |
Why?
|
| Base Sequence | 1 | 1999 | 2730 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1999 | 3464 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 1999 | 1363 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1999 | 2885 | 0.010 |
Why?
|
| Rats | 1 | 1999 | 3370 | 0.010 |
Why?
|